Jeff Yass’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
Jeff Yass's ELDN Position: Q3 2026 in Review
Jeff Yass reduced its Eledon Pharmaceuticals (ELDN) stake by 43% in Q3 2026, selling an estimated $363K and leaving 144,158 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #10507.
Jeff Yass first reported a position in ELDN in Q4 2014 and has held it in 20 quarters since. The position peaked at $5.38M in Q1 2025. 153 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- Jeff Yass held 144,158 shares of Eledon Pharmaceuticals worth $365K as of Q3 2026.
- Jeff Yass sold 108,074 Eledon Pharmaceuticals shares in Q3 2026, an estimated $363K.
- Eledon Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10507 holding.
- Jeff Yass first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 20 quarters since.
- Jeff Yass's Eledon Pharmaceuticals position peaked at $5.38M in Q1 2025.
- 153 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.